Better Artificial Intelligence Stock: Navitas vs. Arm Navitas stock has jumped 188% over the past year, but is it a better buy?
If You'd Invested $1,000 in NVDA 10 Years Ago, Here's How Much You'd Have Today Even a modest investment in Nvidia stock a decade ago would have turned into a staggering amount of money.
Is Recent IPO Stock Bob's Discount Furniture a Buy After a VP Scooped Up 15,000 Shares? This value-focused home furnishings retailer attracted a recent insider buy, according to SEC filings.
How Far Could Netflix Stock Fall? Netflix is still growing at a rapid clip. But as competition intensifies, how sustainable is its growth story?
Oklo vs. NuScale: Which Nuclear Stock Looks Better for Patient Investors? The power needs of AI have created an opportunity for companies pioneering SMR technology.
Jeff Bezos Blown Away By Ryan Gosling's Chemistry With 'Alien Rock Puppet' As Amazon Prime Rolls Exclusive Early Screenings For 'Project Hail Mary' Jeff Bezos praised Ryan Gosling's performance in Project Hail Mary as Amazon rolls out Prime-exclusive early screenings ahead of the film's March 20, 2026 release, while the company's shares slipped despite after-hours gains.
Below $400 Again, Is Tesla Stock a Buy? Tesla is pushing deeper into Robotaxi and AI, but exciting initiatives don't automatically make the stock a buy.
Physical Gold or Silver Stocks? A Deep Dive Into IAU and SIL ETFs Expense ratios, volatility, and fund structure set these two precious metals ETFs apart in ways that matter for portfolio risk.
IBRX Stock Surges Past 4-Year Highs: Analyst Sees over 50% Upside After Anktiva’s Blowout Growth ImmunityBio outlined a three-year plan to position Anktiva as a backbone immunotherapy, advancing more than 30 trials across 10 tumor types.
